# ğŸ§¬ BioLeads AI - Lead Scoring Agent

<div align="center">

**AI-powered lead qualification for 3D in-vitro toxicology solutions**

[![Python](https://img.shields.io/badge/Python-3.8+-blue.svg)](https://python.org)
[![Streamlit](https://img.shields.io/badge/Streamlit-1.28+-red.svg)](https://streamlit.io)
[![License](https://img.shields.io/badge/License-MIT-green.svg)](LICENSE)

[Demo](#-screenshots) â€¢ [Features](#-features) â€¢ [Installation](#-installation) â€¢ [Usage](#-usage) â€¢ [API](#-data-sources)

</div>

---

## ï¿½ Overview

**BioLeads AI** is an **AI-powered lead qualification tool** designed specifically for the biotech industry. It helps Business Development (BD) teams identify high-potential leads who are likely to need **3D in-vitro models for drug toxicology studies**.

---

## ğŸ¯ The Problem It Solves

Biotech BD teams waste hours manually searching across multiple platforms:
- ğŸ” LinkedIn for toxicology directors
- ğŸ“š PubMed for DILI (Drug-Induced Liver Injury) researchers
- ğŸ’° Crunchbase for funded startups
- ğŸ¤ Conference sites for attendees

**BioLeads AI automates this entire process!**

---

## ï¿½ğŸ“¸ Screenshots

### ğŸ”´ Live Data Mode - Real-time PubMed & NIH Data
<img src="assets/dashboard_live.png" alt="BioLeads AI Live Dashboard" width="100%"/>

*Real-time data fetching from PubMed and NIH RePORTER APIs - completely FREE!*

---

### ğŸ“Š Sample Data Mode - Curated Demo Leads
<img src="assets/dashboard_sample.png" alt="BioLeads AI Sample Dashboard" width="100%"/>

*Premium glassmorphism UI with 25 curated demo leads and scoring model visualization*

---

### ğŸ“ˆ Score Distribution & Tier Breakdown
<img src="assets/score_distribution.png" alt="Score Distribution Charts" width="100%"/>

*Interactive Plotly charts showing probability score distribution and lead tier breakdown (Hot, High, Medium, Low)*

---

### ğŸ¢ Company Analysis
<img src="assets/analysis.png" alt="Analysis Dashboard" width="100%"/>

*Average score by company type - identifying Series B biotechs as highest-value targets*

---

## âš™ï¸ How It Works - 3-Stage Pipeline

BioLeads AI uses a sophisticated **3-stage pipeline** to identify, enrich, and rank leads:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                           ğŸ§¬ BIOLEADS AI PIPELINE                                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
     â”‚                      â”‚        â”‚                      â”‚        â”‚                      â”‚
     â”‚   ğŸ“¥ IDENTIFICATION  â”‚        â”‚   ğŸ”¬ ENRICHMENT      â”‚        â”‚   ğŸ“Š RANKING         â”‚
     â”‚                      â”‚        â”‚                      â”‚        â”‚                      â”‚
     â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
     â”‚  â”‚   PubMed API   â”‚  â”‚        â”‚  â”‚   Location     â”‚  â”‚        â”‚  â”‚  5-Signal      â”‚  â”‚
     â”‚  â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚  â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”‚        â”‚  â”‚  Scoring       â”‚  â”‚
     â”‚  â”‚  DILI Papers   â”‚  â”‚   â”€â”€â–º  â”‚  â”‚  Hub cities    â”‚  â”‚   â”€â”€â–º  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚  â”‚
     â”‚  â”‚  Hepatotoxicityâ”‚  â”‚        â”‚  â”‚  (Boston, etc) â”‚  â”‚        â”‚  â”‚  0-100 score   â”‚  â”‚
     â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
     â”‚                      â”‚        â”‚                      â”‚        â”‚                      â”‚
     â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
     â”‚  â”‚  NIH RePORTER  â”‚  â”‚        â”‚  â”‚  Company Info  â”‚  â”‚        â”‚  â”‚  Tier Labels   â”‚  â”‚
     â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚  â”‚
     â”‚  â”‚  Active Grants â”‚  â”‚        â”‚  â”‚  HQ Location   â”‚  â”‚        â”‚  â”‚  ğŸ”¥ Hot (80+)  â”‚  â”‚
     â”‚  â”‚  Liver Tox     â”‚  â”‚        â”‚  â”‚  Company Type  â”‚  â”‚        â”‚  â”‚  âš¡ High (60+) â”‚  â”‚
     â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â”‚  ğŸ“Š Medium     â”‚  â”‚
     â”‚                      â”‚        â”‚                      â”‚        â”‚  â”‚  â„ï¸ Low (<40)  â”‚  â”‚
     â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
     â”‚  â”‚  Conferences   â”‚  â”‚        â”‚  â”‚   Funding      â”‚  â”‚        â”‚                      â”‚
     â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
     â”‚  â”‚  SOT, AACR     â”‚  â”‚        â”‚  â”‚  Series A/B/C â”‚  â”‚        â”‚  â”‚   Priority     â”‚  â”‚
     â”‚  â”‚  Speakers      â”‚  â”‚        â”‚  â”‚  NIH Grants   â”‚  â”‚        â”‚  â”‚   Ranking      â”‚  â”‚
     â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚  â”‚
     â”‚                      â”‚        â”‚                      â”‚        â”‚  â”‚  1, 2, 3...    â”‚  â”‚
     â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
     â”‚  â”‚  Funding News  â”‚  â”‚        â”‚  â”‚  Tech Stack   â”‚  â”‚        â”‚                      â”‚
     â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚        â”‚                      â”‚
     â”‚  â”‚  Series A/B    â”‚  â”‚        â”‚  â”‚  In-vitro     â”‚  â”‚        â”‚                      â”‚
     â”‚  â”‚  Announcements â”‚  â”‚        â”‚  â”‚  models used? â”‚  â”‚        â”‚                      â”‚
     â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚        â”‚                      â”‚
     â”‚                      â”‚        â”‚                      â”‚        â”‚                      â”‚
     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚                              â”‚                               â”‚
              â”‚                              â”‚                               â”‚
              â–¼                              â–¼                               â–¼
     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
     â”‚                                                                                      â”‚
     â”‚                         ğŸ“Š STREAMLIT DASHBOARD OUTPUT                                â”‚
     â”‚                                                                                      â”‚
     â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”‚
     â”‚   â”‚   28        â”‚    â”‚    9        â”‚    â”‚    66       â”‚    â”‚    2        â”‚          â”‚
     â”‚   â”‚   TOTAL     â”‚    â”‚   HOT       â”‚    â”‚   AVG       â”‚    â”‚   DATA      â”‚          â”‚
     â”‚   â”‚   LEADS     â”‚    â”‚   LEADS ï¿½  â”‚    â”‚   SCORE     â”‚    â”‚   SOURCES   â”‚          â”‚
     â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â”‚
     â”‚                                                                                      â”‚
     â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
     â”‚   â”‚  Lead Table  â”‚  Score Distribution  â”‚  Analysis                            â”‚    â”‚
     â”‚   â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚    â”‚
     â”‚   â”‚  Rank â”‚ Tier     â”‚ Score â”‚ Name        â”‚ Title           â”‚ Company        â”‚    â”‚
     â”‚   â”‚  1    â”‚ ğŸ”¥ Hot   â”‚ 100%  â”‚ Dr. Torres  â”‚ Head of Preclin â”‚ Foghorn Ther.  â”‚    â”‚
     â”‚   â”‚  2    â”‚ ğŸ”¥ Hot   â”‚ 115%  â”‚ Dr. Harris  â”‚ Head of Liver   â”‚ Aligos Ther.   â”‚    â”‚
     â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
     â”‚                                                                                      â”‚
     â”‚   ğŸ“¥ Download CSV    ğŸ”„ Refresh                                                      â”‚
     â”‚                                                                                      â”‚
     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ“Š 5-Dimensional Scoring Model

Each lead is scored on **5 signals** out of 100 points:

| Signal | Weight | What It Measures |
|--------|--------|------------------|
| **ğŸ”¬ Scientific Intent** | +40 | Published DILI/hepatic paper in last 2 years |
| **ğŸ‘” Role Fit** | +30 | Title: Director, VP, Head of Toxicology/Safety |
| **ğŸ’° Company Intent** | +20 | Series A/B funding (budget available) |
| **ğŸ§ª Technographic** | +15 | Already uses in-vitro models or NAMs |
| **ğŸ“ Location** | +10 | Hub city: Boston, Basel, Bay Area, UK |

### Score Examples

| Lead Profile | Score | Tier |
|--------------|-------|------|
| ğŸ‘¤ Junior Scientist at unfunded startup | **15/100** | â„ï¸ Low |
| ğŸ‘¤ Research Author with DILI paper | **55/100** | ğŸ“Š Medium |
| ğŸ‘¤ Director of Toxicology at Series A biotech | **70/100** | âš¡ High |
| ğŸ‘¤ Director of Safety at Series B biotech in Cambridge with DILI paper | **95/100** | ğŸ”¥ Hot |

---

## âœ¨ Features

### ğŸ” Multi-Source Intelligence
- **PubMed** - Recent DILI/hepatotoxicity paper authors
- **NIH RePORTER** - Active grant principal investigators
- **Conferences** - SOT, AACR speaker/attendee lists
- **Funding News** - Series A/B biotech announcements

### ğŸ¨ Premium UI
- Dark mode with glassmorphism design
- Interactive Plotly charts
- Real-time metric cards
- One-click CSV export
- Mobile responsive

### âš¡ Live Data Toggle
Switch between:
- **Sample Data** - 25 curated demo leads (instant)
- **Live Mode** - Real-time PubMed + NIH fetching

---

## ğŸš€ Installation

### Prerequisites
- Python 3.8 or higher
- pip package manager

### Quick Start

```bash
# Clone the repository
git clone https://github.com/YOUR_USERNAME/bioleads-ai.git
cd bioleads-ai

# Create virtual environment (recommended)
python -m venv venv
source venv/bin/activate  # On Windows: venv\Scripts\activate

# Install dependencies
pip install -r requirements.txt

# Run the dashboard
python -m streamlit run streamlit_app.py
```

The dashboard opens at **http://localhost:8501** ğŸš€

---

## ğŸ’» Usage

### Running the Dashboard

```bash
python -m streamlit run streamlit_app.py
```

### Running the Pipeline (CLI)

```bash
# Full pipeline run
python main.py

# Test mode with sample data
python main.py --test-run
```

### Dashboard Controls

| Control | Action |
|---------|--------|
| ğŸ“¡ Data Source | Toggle between sample and live data |
| ğŸ” Search | Filter by name, company, or location |
| ğŸ“Š Score Slider | Set minimum probability threshold |
| ğŸ“¥ Download CSV | Export filtered leads for CRM import |
| ğŸ”„ Refresh | Clear cache and fetch fresh data |

---

## ğŸ“¡ Data Sources

All APIs are **completely FREE**:

| Source | API | Rate Limit | Auth Required |
|--------|-----|------------|---------------|
| **PubMed** | NCBI E-utilities | 3/sec | âŒ No |
| **NIH RePORTER** | NIH API | Unlimited | âŒ No |
| **RSS Feeds** | Various | Unlimited | âŒ No |

### How Live Fetching Works

1. **PubMed**: Searches for recent papers with keywords like "DILI", "drug-induced liver injury", "hepatotoxicity", "3D liver model"
2. **NIH RePORTER**: Queries active grants related to liver toxicology and 3D models
3. **Scoring**: Each lead is scored using the 5-signal model
4. **Display**: Results are ranked and displayed in the interactive table

---

## ğŸ“ Project Structure

```
bioleads-ai/
â”œâ”€â”€ ğŸ“„ streamlit_app.py      # Main dashboard (Streamlit)
â”œâ”€â”€ ğŸ“„ main.py               # Pipeline orchestrator
â”œâ”€â”€ ğŸ“„ requirements.txt      # Python dependencies
â”œâ”€â”€ ğŸ“„ README.md             # This file
â”‚
â”œâ”€â”€ ğŸ“‚ app/
â”‚   â”œâ”€â”€ ğŸ“‚ sources/          # Data crawlers
â”‚   â”‚   â”œâ”€â”€ pubmed_crawler.py
â”‚   â”‚   â”œâ”€â”€ crunchbase_crawler.py
â”‚   â”‚   â”œâ”€â”€ conference_crawler.py
â”‚   â”‚   â””â”€â”€ grants_crawler.py
â”‚   â”‚
â”‚   â””â”€â”€ ğŸ“‚ scoring/
â”‚       â””â”€â”€ probability_engine.py
â”‚
â”œâ”€â”€ ğŸ“‚ data/
â”‚   â”œâ”€â”€ sample_leads.json    # 25 demo leads
â”‚   â””â”€â”€ scored_leads.json    # Pipeline output
â”‚
â”œâ”€â”€ ğŸ“‚ assets/               # Screenshots
â”‚   â”œâ”€â”€ dashboard_live.png
â”‚   â”œâ”€â”€ dashboard_sample.png
â”‚   â”œâ”€â”€ score_distribution.png
â”‚   â””â”€â”€ analysis.png
â”‚
â””â”€â”€ ğŸ“‚ .streamlit/
    â””â”€â”€ config.toml          # Dark theme config
```

---

## ğŸ”„ Running Modes

| Mode | Command | Description |
|------|---------|-------------|
| **Dashboard** | `python -m streamlit run streamlit_app.py` | Interactive web UI with live data |
| **CLI Pipeline** | `python main.py` | Batch processing, saves to `scored_leads.json` |
| **Test Mode** | `python main.py --test-run` | Uses sample data only |

---

## â˜ï¸ Deployment

### Streamlit Community Cloud (Free)

1. **Push to GitHub**
```bash
git init
git add .
git commit -m "BioLeads AI - Lead Scoring Agent"
git branch -M main
git remote add origin https://github.com/YOUR_USERNAME/bioleads-ai.git
git push -u origin main
```

2. **Deploy**
   - Go to [share.streamlit.io](https://share.streamlit.io)
   - Connect your GitHub account
   - Select the repository
   - Set main file: `streamlit_app.py`
   - Click **Deploy**

3. **Share** your live URL!

---

## ğŸ› ï¸ Tech Stack

| Layer | Technology |
|-------|------------|
| **Frontend** | Streamlit |
| **Visualization** | Plotly |
| **Data Processing** | Pandas |
| **HTTP Client** | Requests |
| **Web Scraping** | BeautifulSoup4 |
| **Styling** | Custom CSS (Glassmorphism) |

---

## ğŸ¤ Contributing

Contributions are welcome! Please feel free to submit a Pull Request.

1. Fork the repository
2. Create your feature branch (`git checkout -b feature/AmazingFeature`)
3. Commit your changes (`git commit -m 'Add some AmazingFeature'`)
4. Push to the branch (`git push origin feature/AmazingFeature`)
5. Open a Pull Request

---

## ğŸ“„ License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

---

<div align="center">

**Built with â¤ï¸ using Python and Streamlit**

â­ Star this repo if you find it useful!

</div>
